- Home
- GOVX vs BGI Comparison
GOVX vs BGI Comparison
Compare GOVX & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- BGI
- Stock Information
- Founded
- GOVX 2001
- BGI 1879
- Country
- GOVX United States
- BGI Canada
- Employees
- GOVX N/A
- BGI 290
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- GOVX Health Care
- BGI
- Exchange
- GOVX Nasdaq
- BGI Nasdaq
- Market Cap
- GOVX 15.5M
- BGI 17.8M
- IPO Year
- GOVX N/A
- BGI 2005
- Fundamental
- Price
- GOVX $0.44
- BGI N/A
- Analyst Decision
- GOVX Strong Buy
- BGI
- Analyst Count
- GOVX 5
- BGI 0
- Target Price
- GOVX $12.40
- BGI N/A
- AVG Volume (30 Days)
- GOVX 2.4M
- BGI 77.0K
- Earning Date
- GOVX 08-05-2025
- BGI 07-15-2025
- Dividend Yield
- GOVX N/A
- BGI N/A
- EPS Growth
- GOVX N/A
- BGI N/A
- EPS
- GOVX N/A
- BGI N/A
- Revenue
- GOVX $5,591,576.00
- BGI $131,596,265.00
- Revenue This Year
- GOVX N/A
- BGI N/A
- Revenue Next Year
- GOVX N/A
- BGI N/A
- P/E Ratio
- GOVX N/A
- BGI N/A
- Revenue Growth
- GOVX N/A
- BGI 4.01
- 52 Week Low
- GOVX $0.43
- BGI $0.76
- 52 Week High
- GOVX $11.18
- BGI $2.95
- Technical
- Relative Strength Index (RSI)
- GOVX 29.07
- BGI 52.44
- Support Level
- GOVX $0.85
- BGI $0.85
- Resistance Level
- GOVX $0.98
- BGI $0.93
- Average True Range (ATR)
- GOVX 0.15
- BGI 0.06
- MACD
- GOVX -0.04
- BGI 0.01
- Stochastic Oscillator
- GOVX 5.54
- BGI 63.16
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.